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Key words: Cftr; cystic fibrosis; mouse model; conditional knockout; ion transport; intestinal obstruction Mutation of the cystic fibrosis transmembrane conductance regulator (CFTR) gene can lead to cystic fibrosis (CF), an autosomal recessive disorder which occurs in about 1 in every 3,000 Caucasian live births. The CFTR protein is a chloride channel involved in the exchange of fluid and electrolytes across epithelial cells (Gadsby et al., 2006) . CF is a systemic disorder consistently characterized by poor growth, chronic lung infection, exocrine pancreatic insufficiency, intestinal malabsorption, reduced fertility, and shortened lifespan. Many patients with CF experience meconium ileus, distal intestinal obstructive syndrome, delayed puberty, liver disease, and diabetes. Although these phenotypes ultimately arise as a consequence of reduced or absent CFTR function, the wide expression of CFTR throughout the body makes it difficult to establish the mechanism behind the variety of phenotypes. For example, poor growth may be due to loss of CFTR in the intestinal tract, pancreas, neuroendocrine cells, or any combination thereof. CFTR is expressed in many epithelial tissues such as lung (Engelhardt et al., 1992; Trezise and Buchwald, 1991; Trezise et al., 1993a) , nose (Engelhardt et al., 1992) , salivary glands (Manson et al., 1997; Trezise and Buchwald, 1991) , intestine (Manson et al., 1997; Trezise and Buchwald, 1991) , stomach (Manson et al., 1997) , pancreas (Trezise and Buchwald, 1991; Trezise et al., 1993a) , liver (Yang et al., 1993) , gall bladder (Yang et al., 1993) , sweat gland (Kartner et al., 1992) , kidney (Todd-Turla et al., 1996) , male and female reproductive tracts (Trezise et al., 1993a,b) , thyroid (Devuyst et al., 1997) and the early embryo (Ben-Chetrit et al., 2002) as well as nonepithelial tissues such as heart (Davies et al., 2004) , brain (Mulberg et al., 1998) , smooth muscle (Robert et al., 2004) and lymphocytes (Yoshimura et al., 1991) . The identification of CFTR's role in each of these tissues will facilitate the understanding of CF disease.
Currently available mouse models of CF were created using conventional gene targeting strategies leading to constitutive null or hypomorphic alleles of Cftr. While the lung pathology so prevalent in human CF patients is mostly absent in these mouse models, Cftr-deficient mice do display multiple CF phenotypes including poor growth, intestinal obstruction, delayed puberty, infertility, pancreatic abnormalities, gall bladder abnormalities, and decreased survival (Colledge et al., 1995; Delaney et al., 1996; Grubb and Boucher, 1999; Hasty et al., 1995; Hodges et al., 2008; Jin et al., 2006; Kent et al., 1996; O'Neal et al., 1993; Ratcliff et al., 1993; Rozmahel et al., 1996; Snouwaert et al., 1992; Zeiher et al., 1995) . As in the human, it is not clear how the etiology of these phenotypes relate to each other, because in these global knockouts, the physiology of the tissues involved overlap. Thus, fully understanding the effects of losing Cftr in individual tissues or organs of the mouse cannot be accomplished through conventional gene knockout approach.
To better understand the physiologic relationship of CF-affected tissues and organs, we created a conditional null Cftr allele in the mouse. Here we describe the generation of a murine Cftr allele with loxP sites flanking exon 10 allowing conditional deletion of exon 10 by directed expression of the bacterial Cre recombinase. Exon 10 of Cftr was chosen as a target because of its known importance in protein function. Not only are many exon 10 mutations associated with CF in humans (Tsui, 1992) but also the disruption of exon 10 in mice is known to create severe CF phenotypes (Colledge et al., 1995; Ratcliff et al., 1993; Snouwaert et al., 1992; Zeiher et al., 1995) . In addition, future comparison of this model with other null or hypmorphic Cftr alleles of exon 10 should be straightforward because the same region of the gene is altered in other Cftr mouse models.
The mouse Cftr gene consists of 27 exons and spans over 150 kb. To generate a conditional null allele of Cftr, we constructed a targeting vector in which exon 10 of the Cftr gene was flanked by loxP sites (see Fig. 1 ), or ''floxed''. The vector also contained selectable markers for both positive (neomycin resistance cassette) and negative (herpes thymidine kinase gene, HTK) selection of mouse embryonic stem (ES) cells. The neomycin cassette was surrounded by loxP sites allowing for its removal with Cre recombinase expression as well. R1 ES cells were electroporated with the targeting vector and neomycin resistant colonies were used for DNA blot confirmation of correct targeting of the 3 0 end of the construct (see Fig. 1 ). Three ES colonies out of 201(1.5%) tested were correctly targeted. Additional PCR strategies were used to confirm correct homologous recombination on both the 5 0 and 3 0 ends (data not shown). Chimeras were generated from two of the correctly targeted ES colonies using standard procedures. Germline transmission of the conditional null allele of Cftr (Cftr fl10neo ) was confirmed by both Southern blotting and PCR analysis (see Fig. 1 ). The neomycin cassette was removed in subsequent generations of mice (referred to as Cftr fl10 ) using Cre recombinase to circumvent any possible complications caused by the presence of the neomycin cassette. Mice homozygous for the conditional null allele (Cftr fl10/fl10 ) were indistinguishable from wild-type mice in growth, survival, and Cftr activity.
To validate the utility of our conditional null Cftr allele, we generated a constitutive deletion of exon 10 by crossing mice with the Cftr fl10 allele to mice expressing Cre recombinase during the final stages of spermatogenesis through a protamine promoter (O'Gorman et al., 1997) . Male mice heterozygous for the Cftr fl10 allele and positive for protamine Cre recombinase were mated to wild-type females resulting in a portion of offspring heterozygous for a deleted exon 10 allele (Cftr D10/1 ). The Cftr D10/1 mice were mated to generate Cftr D10/D10 mice which were verified by PCR analysis (see Fig. 1 . The removal of exon 10 in Cftr creates an in-frame deletion in which Cftr is transcribed but exon 10 is absent from the RNA (see Fig. 2 ). Antibodies raised to Cftr will not distinguish between Cftr containing and lacking exon 10 and so functional assays were employed to determine the effects of the allele. To test for Cftr function, we assayed Cftr's ability to conduct chloride across the nasal and intestinal epithelium in Cftr fll0/fl10 , Cftr 1/1 , and Cftr D10/D10 mice. Nasal potential difference (NPD) across the nasal epithelium was measured before and after the addition of a chloride-free solution containing forskolin (Fig. 3a) . Forskolin stimulates adenylate cyclase, leading to activation of Cftr through protein kinase A-mediated phosphorylation. Challenge with a nominally chloride-free solution provides a concentration gradient in favor of chloride secretion. NonCF animals display chloride secretion in response to this challenge, generat- , and Cftr
mice. Amplification of exons 8-11 from cDNA created from RNA from lung (L) and intestine (Int.) display a 563-bp product from the wild-type allele and a 371-bp product from the exon 10 deleted allele (the 192-bp exon 10 is absent in the Cftr D10 allele). ing a lumen-negative potential difference, while CF mice do not respond (Fig. 3a) . After solution perfusion, Cftr fll0/fl10 animals showed a change in NPD of 215.8 6 5.2 mV, Cftr 1/1 animals showed a change in NPD of 225.0 6 6.8 mV, while Cftr D10/D10 animals showed a change of only 20.5 6 0.5 mV (P < 0.01 for Cftr D10/D10 vs. either control group; three mice per genotype). The lack of change in NPD in Cftr D10/D10 mice is consistent with absence of Cftr activity.
Cftr function in the intestinal epithelium was assessed by measuring short-circuit current across intestinal sections before and after stimulation by a cocktail of forskolin and IBMX to raise cAMP levels. This maneuver increases short-circuit current in nonCF animals but not in CF animals (Fig. 3b) . Intestinal sections from the ileum, jejunum, duodenum, cecum, and colon were tested for change in short-circuit current and all showed similar differences between Cftr fll0/fl10 , Cftr 1/1 , and Cftr D10/D10 animals ( Table 1 ). The lack of increase in short-circuit current in Cftr D10/D10 mice is consistent with the absence of Cftr function in the intestinal epithelium.
The Cftr D10/D10 mice displayed decreased growth and decreased survival (see Fig. 4 ) similar to other published reports of CF mouse models (Colledge et al., 1995; Delaney et al., 1996; Hasty et al., 1995; O'Neal et al., 1993; Ratcliff et al., 1993; Rozmahel et al., 1996; Snouwaert et al., 1992; Zeiher et al., 1995) . Growth was reduced in Cftr D10/D10 mice by an average of 17%-39% depending on the age of the animals (see Fig. 4 ) similar to the 20%-50% growth reduction observed in Cftr null models. The Cftr D10/D10 mice also displayed decreased survival compared with littermates with only 32% surviving up to 40 days similar to the 5%-40% survival observed in Cftr null models. The majority of deaths in Cftr D10/D10 mice occurred shortly after weaning (20-30 days) due to intestinal obstruction (Figs. 4c and 5 ). Further examination of the intestine of Cftr D10/D10 mice revealed typical intestinal histology observed in CF mouse models including increased luminal mucus accumulation and goblet cell hyperplasia (see Fig. 5 ). , and Cftr
1/D10
, so they were combined).
These results indicate that loss of exon 10 results in a functionally null phenotype in mice, displaying decreased growth, high incidence of intestinal obstruction, goblet cell hyperplasia, and loss of normal transepithelial ion transport. As this allele can be generated in a conditional fashion using the Cftr fl10 mouse and regulated Cre expression, it provides a tool to study tissue-specific and temporal effects of losing Cftr. For example, decreased growth and intestinal obstruction in CF mice have been hypothesized to be due to loss of Cftr activity in the intestinal epithelium. This hypothesis can be tested by crossing the Cftr fl10 mouse with a mouse in which Cre recombinase expression is driven by the villin promoter so that Cre is expressed specifically in the intestinal epithelium (Madison et al., 2002) . Delayed growth in CF mice may also have a neuroendocrine origin given the multiple reports of Cftr expression in the brain (Mulberg et al., 1998; Weyler et al., 1999) . Possible Cftr function in the nervous system could be examined by crossing the Cftr fl10 mouse with a mouse in which Cre expression is driven by the nestin promoter so that Cre is expressed specifically in the central and peripheral nervous system (Tronche et al., 1999) . Finally, one can test the importance of Cftr activity on the development of the mouse (e.g., in utero, postnatal, pubertal, and adult) by deleting Cftr function in the whole mouse at different time points by crossing the Cftr fl10 mouse with a mouse in which Cre expression is driven by an inducible promoter (e.g., Badea et al., 2003) . The ability to delete Cftr in a tissue or time-dependent manner in the mouse will not only help understand how Cftr function contributes to the function and development of each tissue but how the absence of CFTR in these same tissues leads to CF disease in humans.
METHODS AND MATERIALS

Generation of the Cftr Floxed Allele
Genomic DNA was isolated from R1 cells. The targeting vector consisted of amplified fragments of Cftr that included 4.4 kb of intron 9 (5 0 arm), 4.5 kb of intron 10 (3 0 arm), and 0.5 kb consisting of exon 10 and 150 bp of intron 9 and 10 on each side. These fragments were subcloned into pBluescript. Two loxP sites surrounding the phosphoglycerol kinase promoter attached to a neomycinresistance gene (PGK-neocassette) were inserted downstream of exon 10 while the third loxP site was inserted upstream of exon 10. A HTK cassette was inserted downstream of intron 10. A schematic of the targeting construct is shown in Figure 1 . The linearized targeting vector was transfected into R1 ES cells and neomycin resistant colonies were screened by Southern blot using a 3 0 external probe with SphI digested genomic DNA. Three colonies out of 201(1.5%) were correctly targeted. These correctly targeted ES cells were microinjected into C57BL/6 blastocysts and transferred to a pseudopregnant mouse. Eight chimeric males were bred to C57BL/6 females and F1 agouti offspring were analyzed by Southern blot and PCR genotyping to confirm germline transmission of the conditional Cftr null allele. TAATCCAAGA-3 0 ) and P3 (5 0 -AGCCCCTCGAGGGACC-TAAT-3 0 ) were used (Fig. 1c,d ). PCR reactions were completed for 40 cycles of 958C for 30 seconds, 588C for 1 min and 728C for 1 min.
Lungs and intestines were collected from Cftr 1/1, 1/2, and 2/2 animals and total RNA was isolated using Trizol (Invitrogen) per the manufacturer's instructions. One lg of RNA was reverse transcribed into cDNA with MMLV. cDNA was used in PCR analysis to amplify Cftr exons 8-11 to detect wild-type allele(563 bp) and excised exon 10 allele (371 bp) expression. PCRs were completed for 40 cycles of 958C for 30 sec, 558C for 30 sec, and 728C for 1 min with primers (5 0 -CCACAGGCA-TAATCATGGAA-3 0 ) and (5 0 -TGTGACTCCACCTTCTC-CAA-3 0 ).
Histology
Mouse intestines were isolated and fixed in 10% formalin, embedded in paraffin and sectioned every 5 lm. Periodic acid schiff (PAS) staining of these sections were completed to detect mucus accumulation.
Bioelectric Measurements
The potential difference (PD) across the nasal epithelium of the mice was measured according to procedures previously described elsewhere (Brady et al., 2001; Kelley et al., 1997) , with some modifications. Mice were anesthetized with 8.5 mg/ml ketamine, 1.7 mg/ml xylazine, and 0.3 mg/ml acepromazine in sterile saline. Animals were dosed intraperitoneally with 0.012 ml/g mouse weight. A PE-10 tube stretched to one-half the original diameter was inserted 2 mm into the mouse nostril and placed against the septum. With the use of a syringe pump (model A-99; Razel Scientific Instruments) and 3-ml syringes, N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid (HEPES)-buffered Ringer's solution perfused into the nostril at a rate of 5 ml/min. Valves controlled the solution which entered the nostril, with a 15-sec delay until the new solution reached the nasal epithelium. Readings were taken until a steady-state value was reached before perfusing the nasal epithelium with a new solution. Paper wicks were used to absorb excess liquid from the mouth and opposite nostril of the mouse being tested. A trachea tube consisting of an Angiocath IV Catheter was inserted into the mouse trachea to facilitate breathing. Bridges (4% agar) connected the tubing to calomel electrodes, and each bridge was made in the same solution as the perfusate it measured (HEPES-buffered Ringer's or chloridefree HEPES-buffered Ringer's). A needle containing 4% agar in HEPES-buffered Ringer's was placed subcutaneously in the mouse's back and connected to another calomel electrode to serve as a reference. The measuring and reference calomel electrodes were situated in a KCl bath in which one end of the agar bridge was also immersed. The other end of the measuring electrode's bridge was in contact with the perfusate 20 cm from the mouse nose. The transepithelial difference was measured with a voltmeter (model ISO-DAM-D; World Precision Instruments), and the signal was recorded on a chart recorder (model BD112; Kipp and Zonen). The PD measurements were corrected for junction potentials, and changes in PD values were calculated by subtracting the value after 4 min of perfusion with chloride-free Ringer's solution containing forskolin from the value when the perfusion began. Before measurements, the system was zeroed by adjusting the voltmeter after connecting the reference needle to the tube normally placed in the mouse nose to complete the circuit.
Electrolyte transport was investigated in the intestine of 8-to 12-week-old animals that were fasted overnight. Mice were rendered unconscious by CO 2 asphyxiation and killed by exsanguination. The large and small intestines were removed and immediately placed in ice-cold HEPES-buffered Ringer's solution (in mM: 138 NaCl, 5 KCl, 2.5 Na 2 HPO 4 , 1.8 CaCl 2 , 1.0 MgSO 4 , and 10 HEPESNaOH, pH 7.4) for dissection. The intestine was cut longitudinally, and the contents were removed with a stream of Ringer's solution. The tissue was stretched and pinned in an Ussing chamber with an aperture of 0.125 cm 2 . Tissues were bathed on both sides by 6-8 ml of mammalian Krebs-Ringer bicarbonate solution [in mM: 115 NaCl, 25 NaHCO 3 , 5 KCl, 2.5 Na 2 HPO 4 , 1.8 CaCl 2 , 1.0 MgSO 4 , and 10 glucose, pH 7.4 (mannitol replaced glucose in the apical bathing solution)], which was warmed to 378C and circulated with 95% O 2 -5% CO 2 through gas lifts. Transepithelial electrical voltage difference (V ms ) was measured between two Ringer-agar bridges. Calomel cells connected the bridges to a highimpedance voltmeter (DVC 1,000 Voltage/Current Clamp, World Precision Instruments). Current from an external DC source was passed by silver-silver chloride electrodes and Ringer-agar bridges to clamp the spontaneous V ms to zero. The current required (short-circuit current, I sc ) was corrected for solution resistance between the tips of the voltage-sensing electrodes and recorded. Tissues were maintained with V ms clamped to zero (short-circuit conditions). At 60-sec intervals, V ms was clamped to 12 mV for 3 sec to calculate transepithelial resistance (R ms ). Tissues were mounted and observed until the I sc stabilized (generally 10-15 min), at which time experimental maneuvers were begun.
